ghk cu research news 2025 GHK-Cu – Neurogan Health GHK-Cu: The “Beauty Peptide” You're

Endocrinology , 142(12), 51825189

R.Shariati-IevariS.AjisebutuA.NguyenA.DesmondF.et al (2019)

The strong correlation between entry of the receptor into the desensitised state and the extent of 2L S327 phosphorylation, and in particular, the observation that the increased phosphorylation was completely blocked by expression of the non-desensitizing 1 V296L mutant, strongly suggests that entry of the receptors into the desensitized state is required for agonist-induced 2L S327 phosphorylation

Key Takeaways Injectable GHK-Cu: 12mg per injection, once or twice daily Topical GHK-Cu cream/serum: 24% concentration, once or twice daily Cycle length: 812 weeks on, 4 weeks off 100mg vial at 2mg/day = 50 days of use Results start showing at weeks 34, significant at weeks 68 Most popular setup: 100mg vial + 2mL BAC water = 50mg/mL concentration Free calculator: Reconstitution Calculator The standard injectable GHK-Cu dose is 12mg per day, subcutaneously